Literature DB >> 7996851

The expression of regenerative growth factors in chronic liver injury and repair.

P R Aldana1, M E Goerke, S C Carr, T F Tracy.   

Abstract

Acute hepatic injury initiates known cellular and molecular events for regeneration. In contrast, the molecular mechanisms of repair following chronic liver injuries have not been defined. Transforming growth factor alpha (TGF alpha) and hepatocyte growth factor (HGF) are hepatocyte mitogens whose in vivo expression in liver is central to the regulation of regeneration. To study the role of TGF alpha and HGF in liver injury and repair, we used a model of reversible biliary obstruction without a bilioenteric anastomosis. In rats, the common bile duct was obstructed either by a vessel loop suspended from the abdominal wall (LOOP) or by ligation and division (DLD). After 7 days of obstruction, animals were autopsied or were decompressed by subcutaneous release of the loop and then autopsied at 1, 2, 4, 7, or 10 days of postdecompression. Serum bilirubin (mg/dl) increased to 14.8 +/- 2.9 (DLD) and 10.3 +/- 3.0 (LOOP) (+/- SEM, NS, ANOVA) at 7 days of obstruction. Liver sections demonstrated equal ductal hyperplasia and collagen deposition after LOOP and DLD. Biliary decompression reversed bile duct proliferation and normalized bilirubin. Analysis of injured and repairing liver mRNA by ribonuclease protection assay showed that TGF alpha mRNA levels were not significantly altered by injury or during repair. HGF mRNA was elevated following obstruction and showed increased expression 1 day after decompression, peaking at 2 days of repair. This evidence of modulation of HGF during liver repair following chronic cholestatic injury suggests that HGF may have a role in cellular proliferation during repair or act as a compensatory growth factor during injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996851     DOI: 10.1006/jsre.1994.1206

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  10 in total

1.  Effects of sulfasalazine on lipid peroxidation and histologic liver damage in a rat model of obstructive jaundice and obstructive jaundice with lipopolysaccharide-induced sepsis.

Authors:  Musa Dirlik; Aydin Karahan; Hakan Canbaz; Mehmet Caglikulekci; Ayşe Polat; Lulufer Tamer; Suha Aydin
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

2.  Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction.

Authors:  J K Olynyk; G C Yeoh; G A Ramm; S L Clarke; P M Hall; R S Britton; B R Bacon; T F Tracy
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

3.  The NF-kappaB inhibitors attenuate hepatic injury in bile duct ligated rats.

Authors:  Savaş Demirbilek; Melih Akin; Kubilay Gürünlüoğlu; Nasuhi E Aydin; Memet H Emre; Erkan Taş; Rauf T Aksoy; Selma Ay
Journal:  Pediatr Surg Int       Date:  2006-07-08       Impact factor: 1.827

4.  Neutrophil depletion blocks early collagen degradation in repairing cholestatic rat livers.

Authors:  Mark W Harty; Christopher S Muratore; Elaine F Papa; Michael S Gart; Grant A Ramm; Stephen H Gregory; Thomas F Tracy
Journal:  Am J Pathol       Date:  2010-01-28       Impact factor: 4.307

5.  Transforming growth factor alpha levels in liver and blood correlate better than hepatocyte growth factor with hepatocyte proliferation during liver regeneration.

Authors:  T Tomiya; I Ogata; K Fujiwara
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

6.  Fluvastatin reduced liver injury in rat model of extrahepatic cholestasis.

Authors:  Savaş Demirbilek; Erkan Tas; Kubilay Gurunluoglu; Melih Akin; Rauf T Aksoy; Memet H Emre; Nasuhi E Aydin; Selma Ay; Nilufer Ozatay
Journal:  Pediatr Surg Int       Date:  2006-11-04       Impact factor: 1.827

7.  Regulation and function of trefoil factor family 3 expression in the biliary tree.

Authors:  Isao Nozaki; John G Lunz; Susan Specht; Jong-In Park; Andrew S Giraud; Noriko Murase; Anthony J Demetris
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

8.  Inhibition of neoplastic development in the liver by hepatocyte growth factor in a transgenic mouse model.

Authors:  E Santoni-Rugiu; K H Preisegger; A Kiss; T Audolfsson; G Shiota; E V Schmidt; S S Thorgeirsson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration.

Authors:  Barbara Lukomska; Joanna Dluzniewska; Jerzy Polanski; Leszek Zajac
Journal:  Comp Hepatol       Date:  2004-01-14

10.  The role of growth factors on hepatic damage in rats with obstructive jaundice.

Authors:  Ozgur Turk; Bartu Badak; Ersin Ates; Emine Dundar; Emine Sutken
Journal:  Springerplus       Date:  2016-08-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.